A detailed history of Geode Capital Management, LLC transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 768,388 shares of LYRA stock, worth $138,309. This represents 0.0% of its overall portfolio holdings.

Number of Shares
768,388
Previous 755,095 1.76%
Holding current value
$138,309
Previous $211,000 5.69%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.24 - $0.34 $3,190 - $4,519
13,293 Added 1.76%
768,388 $199,000
Q2 2024

Aug 09, 2024

BUY
$0.26 - $6.25 $102,872 - $2.47 Million
395,664 Added 110.08%
755,095 $211,000
Q1 2024

May 13, 2024

BUY
$4.55 - $6.53 $104,527 - $150,013
22,973 Added 6.83%
359,431 $2.24 Million
Q4 2023

Feb 13, 2024

BUY
$2.82 - $5.24 $78,305 - $145,504
27,768 Added 9.0%
336,458 $1.76 Million
Q3 2023

Nov 13, 2023

BUY
$2.95 - $4.8 $471,557 - $767,280
159,850 Added 107.4%
308,690 $1.21 Million
Q4 2022

Feb 13, 2023

BUY
$2.44 - $5.42 $4,833 - $10,737
1,981 Added 1.35%
148,840 $467,000
Q3 2022

Nov 14, 2022

BUY
$4.95 - $6.6 $130,595 - $174,127
26,383 Added 21.9%
146,859 $735,000
Q2 2022

Aug 12, 2022

BUY
$4.12 - $7.51 $342,009 - $623,420
83,012 Added 221.58%
120,476 $680,000
Q1 2022

May 13, 2022

BUY
$3.5 - $5.36 $5,061 - $7,750
1,446 Added 4.01%
37,464 $150,000
Q3 2021

Nov 12, 2021

SELL
$6.06 - $9.43 $509 - $792
-84 Reduced 0.23%
36,018 $329,000
Q2 2021

Aug 13, 2021

SELL
$6.91 - $12.59 $374,376 - $682,113
-54,179 Reduced 60.01%
36,102 $289,000
Q1 2021

May 12, 2021

BUY
$10.38 - $15.61 $225,910 - $339,736
21,764 Added 31.76%
90,281 $1.05 Million
Q4 2020

Feb 12, 2021

BUY
$9.28 - $13.88 $259,904 - $388,737
28,007 Added 69.14%
68,517 $781,000
Q3 2020

Nov 13, 2020

BUY
$10.61 - $13.96 $78,047 - $102,689
7,356 Added 22.19%
40,510 $452,000
Q2 2020

Aug 13, 2020

BUY
$10.91 - $18.56 $361,710 - $615,338
33,154 New
33,154 $375,000

Others Institutions Holding LYRA

About Lyra Therapeutics, Inc.


  • Ticker LYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,826,400
  • Market Cap $5.73M
  • Description
  • Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...
More about LYRA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.